Author

W. W. Ho

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

A. S. Kumar· 2 shared S. Chatterjee· 2 shared A. H. Sharpe· 1 shared C. Chuang· 1 shared D. A. Reardon· 1 shared D. Jones· 1 shared E. M. Perez· 1 shared E. Pereira· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. S. Kumar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Breast cancer progression and metastasis to lymph nodes reveals cancer cell plasticity and MHC class II-mediated immune regulation

P.-J. Lei, E. Pereira, P. Andersson, Z. Amoozgar, J. W. V. Wijnbergen, M. J. O'Melia, H. Zhou, S. Chatterjee, W. W. Ho, J. M. Posada, A. S. Kumar, S. Morita, C. Chuang, I. Ergin, D. Jones, , T. P. Padera

This study identifies MHC class II expression in metastatic breast cancer cells and shows its role in immune evasion and tumor progression through IFN-gamma and JAK/STAT signaling.

bioRxiv · Oct 30, 2022Cancer Biology

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma

M. Datta, S. Chatterjee, E. M. Perez, S. Gritsch, S. Roberge, M. Duquette, I. X. Chen, K. Naxerova, A. S. Kumar, M. Ghosh, K. E. Emblem, M. R. Ng, W. W. Ho, P. Kumar, S. Krishnan, , R. K. Jain

Losartan prevents ICB-induced cerebral edema and improves survival in glioblastoma mice, with a predictive immune signature identified.

bioRxiv · Jun 28, 2022 · PreprintCancer Biology